+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID03032835

Partners Calciphylaxis Biobank and Patient Registry for Understanding Calciphylaxis

Led by Massachusetts General Hospital · Updated on 2026-09-14

300

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Calciphylaxis is a rare and serious vascular calcification disorder that affects the small blood vessels in the skin. The condition is not well understood, with significant gaps in knowledge about its causes and risk factors. Currently, there is no effective treatment for calciphylaxis, and challenges such as its rare occurrence and limited collaborative research have hindered progress in care. This research project, known as the Partners Calciphylaxis Biorepository PCB, aims to improve understanding of calciphylaxis by collecting and storing patient samples through an organized repository. The study collaborates with the Partners Biobank, which manages the storage and distribution of these samples following their procedures. There is no intervention or treatment administered in this study. Participants will provide consent and contribute samples for research purposes. The study will track outcomes including changes in skin lesions over 6 months, pain improvements within 4 weeks, and survival up to 5 years. The study is observational and involves monitoring patients over time without active treatment. Participation may last several years as researchers collect data and samples to better understand calciphylaxis.

CONDITIONS

Brief Title

Partners Calciphylaxis Biobank

Research Team

S

Sagar U Nigwekar, MD, MMSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here